0001062993-22-008679.txt : 20220325 0001062993-22-008679.hdr.sgml : 20220325 20220325190042 ACCESSION NUMBER: 0001062993-22-008679 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220323 FILED AS OF DATE: 20220325 DATE AS OF CHANGE: 20220325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Brien James Michael CENTRAL INDEX KEY: 0001632111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40886 FILM NUMBER: 22772845 MAIL ADDRESS: STREET 1: C/O ENZO BIOCHEM INC. STREET 2: 527 MADISON AVE. CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COGNITION THERAPEUTICS INC CENTRAL INDEX KEY: 0001455365 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2403 SIDNEY STREET STREET 2: SUITE 261 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: 412-481-2210 MAIL ADDRESS: STREET 1: 2500 WESTCHESTER AVE CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: COGNITION THERAPUTICS INC DATE OF NAME CHANGE: 20090204 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-03-23 0001455365 COGNITION THERAPEUTICS INC CGTX 0001632111 O'Brien James Michael C/O COGNITION THERAPEUTICS, INC. 2500 WESTCHESTER AVE. PURCHASE NY 10577 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 3.05 2022-03-23 4 A 0 50000 0 A 2032-03-23 Common Stock 50000 50000 D The option vests 25% on March 23, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer on such vesting date. /s/ James O'Brien 2022-03-25